NCT00117013View on ClinicalTrials.gov

A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 28, 2005

Primary Completion Date

October 25, 2010

Study Completion Date

October 25, 2010

Conditions
Neoplasms
Interventions
DRUG

Fluorine-19-Fluoroded Xyglucose

DRUG

Topotecan

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00117013 - A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a | Biotech Hunter | Biotech Hunter